title: Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease.
authors.affiliation: Department of Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105.
authors.forename: R
authors.initials: R
authors.lastname: Davis
authors.forename: C
authors.initials: C
authors.lastname: Raby
authors.forename: M J
authors.initials: MJ
authors.lastname: Callahan
authors.forename: W
authors.initials: W
authors.lastname: Lipinski
authors.forename: R
authors.initials: R
authors.lastname: Schwarz
authors.forename: D T
authors.initials: DT
authors.lastname: Dudley
authors.forename: D
authors.initials: D
authors.lastname: Lauffer
authors.forename: P
authors.initials: P
authors.lastname: Reece
authors.forename: J
authors.initials: J
authors.lastname: Jaen
authors.forename: H
authors.initials: H
authors.lastname: Tecle
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism; D005769:Gastrointestinal Motility / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008253:Macaca mulatta; D051379:Mice; D008810:Mice, Inbred C57BL; D009928:Organ Specificity; D010277:Parasympathomimetics / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011976:Receptors, Muscarinic / Q000145:classification / Q000187:drug effects* / Q000502:physiology
chemical_list: D010277:Parasympathomimetics; D011976:Receptors, Muscarinic; D000242:Cyclic AMP